JACINTA OKEKE: Open Payments
NPI 1861975575 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,524 in 50 payments from 14 companies in 2025. Trend: 2023 $577 · 2024 $1,262 · 2025 $1,524
Food & beverage: $1,524
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $302 |
| Alkermes, Inc. | 7 | $164 |
| Neurocrine BioSciences, Inc. | 5 | $151 |
| Teva Pharmaceuticals USA, Inc. | 10 | $136 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Boston Scientific Corporation | 1 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| EVOKE PHARMA, INC. | 1 | $81 |
Products named: INVEGA, INGREZZA, BREZTRI, CAPLYTA, WATCHMAN FLX, ABILIFY MAINTENA, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
